Skip to content
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Rights issue 2023
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Native ads
Contact us
Menu
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Rights issue 2023
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Native ads
Contact us
EN
SV
Press releases
Category
All
Regulatory
Non-Regulatory
Interim
Annual
Year
All
2023
2022
2023
2023-10-02 08:00
Prolight Diagnostics publishes investor letter for October 2023
Regulatory
2023-09-06 08:00
Merger Market publishes interview with Prolight Diagnostics CEO, Ulf Bladin
2023-08-29 08:00
Prolight Diagnostics publishes half-year report, 2023
Regulatory
MAR
2023-07-28 08:00
Prolight Diagnostics publishes investor letter for July 2023
Regulatory
2023-07-25 08:00
Prolight Diagnostics publishes investor letter for July 2023
Regulatory
2023-07-12 08:00
Prolight Diagnostics showcases breakthrough POC technology at the AACC Annual Scientific Meeting & Clinical Lab Expo
Regulatorisk
2023-06-13 08:00
Prolight Diagnostics shows proof-of-performance for high-sensitive troponin
Regulatorisk
MAR
2023-05-30 09:05
BioStock Life Science Spring Summit with Prolight Diagnostics
2023-05-11 17:40
Prolight Diagnostics publishes quarterly report Q1, 2023
Regulatory
MAR
2023-05-11 16:30
Annual General Meeting of Prolight Diagnostics AB (publ) on 11 May 2023
Regulatory
Previous
Next
